By Jenny A | Posted - Oct 31st, 2019

 

 

 

 

Our Next Show: Modifying Multiple Myeloma Care for Elderly or Frail Patients with Tanya Wildes, MD of Washington University, Wednesday, Nov 6 @ Noon Central

Wednesday, November 6 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm Eastern

Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer

Many myeloma patients are elderly, with the average age of diagnosis being 68. If individuals are fit and active, they can typically receive the "standard of care" drugs such as stem cell transplant or triplet drug combinations. But many individuals may be frail or have other health conditions that would required doctors to adjust treatment accordingly. Dr. Tanya Wildes, MD of the Washington University Siteman Cancer Institute shares how treatment can be modified for older or more frail patients and how therapy can be practically personalized for us all. 

Thank you to our episode sponsor, Takeda Oncology 

 

 
Jenny A
About the Author

Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
AmazonSmile
 

MORE MYELOMA CROWD NEWS

Thanks to our site sponsors:

Takeda Oncology Celgene Adaptive biotechnologies